Literature DB >> 18243806

Fetal dysrhythmias.

Olus Api1, Julene S Carvalho.   

Abstract

Fetal cardiac dysrhythmias are potentially life-threatening conditions. However, intermittent extrasystoles, which are frequently encountered in clinical practice, do not require treatment. Sustained forms of brady- and tachyarrhythmias might require fetal intervention. Fetal echocardiography is essential not only to establish the diagnosis but also to monitor fetal response to therapy. In the last decade, improvements in ultrasound methodology and new diagnostic tools have contributed to better diagnostic accuracy and to a greater understanding of the electrophysiological mechanisms involved in fetal cardiac dysrhythmias. The most common form of supraventricular tachycardia - that caused by an atrioventricular re-entry circuit - should be differentiated from other forms of tachyarrhythmias, such as atrial flutter and atrial ectopic tachycardia. Ventricular tachycardia is rare in the fetus. Sustained tachycardias, intermittent or not, might be associated with the development of congestive heart failure and hydrops fetalis. Prompt treatment with either anti-arrhythmic drugs or delivery must be considered. Persistent fetal bradycardias associated with complete heart block are also potentially dangerous, whereas bradyarrhythmia due to blocked ectopy is well tolerated in pregnancy. Heart block can be associated with maternal anti-Ro/La autoantibodies or develop in fetuses with left atrial isomerism or with malformations involving the atrioventricular junction. The treatment of fetuses with immune-mediated heart block remains debatable. The use of antenatal steroid therapy is not widely accepted and there is concern over the risks and benefits of its use in the fetus. Direct fetal cardiac pacing has rarely been attempted.

Entities:  

Mesh:

Year:  2008        PMID: 18243806     DOI: 10.1016/j.bpobgyn.2008.01.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  5 in total

Review 1.  Prenatal pharmacotherapy for fetal anomalies: a 2011 update.

Authors:  Lisa Hui; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2011-06-03       Impact factor: 3.050

2.  Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.

Authors:  Kevin A Hinkle; Shabnam Peyvandi; Corey Stiver; Stacy A S Killen; Hsin Yi Weng; Susan P Etheridge; Michael D Puchalski
Journal:  Pediatr Cardiol       Date:  2017-06-29       Impact factor: 1.655

3.  Non-immune hydrops foetalis due to foetal tachyarrhythmia-management with transplacental amiodarone.

Authors:  Mukti Sharma; K Kapur; B K Goyal; S Narayan; Vinay Jetley
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Postnatal outcome in patients with fetal tachycardia.

Authors:  Shreya Moodley; Shubhayan Sanatani; James E Potts; George G S Sandor
Journal:  Pediatr Cardiol       Date:  2012-05-26       Impact factor: 1.655

Review 5.  Evaluation and management of bradycardia in neonates and children.

Authors:  Alban-Elouen Baruteau; James C Perry; Shubhayan Sanatani; Minoru Horie; Anne M Dubin
Journal:  Eur J Pediatr       Date:  2016-01-16       Impact factor: 3.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.